Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hormonal therapies are safe and effective for treating adult women's acne.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Taking L-cystine and vitamin B6 can prevent hair loss caused by smoke in mice.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Growing hair follicles have high mitochondrial activity and ROS in specific regions, aiding hair formation.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

The study found that a specific area of the hair follicle helps start hair growth by reducing the blocking effects on certain cells and controlling growth signals.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.